Freely Filtered, a NephJC Podcast

Freely Filtered 031: Roxadustat

03.28.2021 - By NephJC TeamPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Roxadustat is the first HIF stabilizer up for FDA approval. There have been a number of roxa publications and today we took at the two most recent.

One is a pooled analysis of incident dialysis patients: roxa versus epoetin alpha. And The second is a pre-dialysis CKD study of roxa versus placebo.

Roxa represents well, but devils in the details. Join the filtrate as we go deep on roxa!

More episodes from Freely Filtered, a NephJC Podcast